Brigham Young University

BYU ScholarsArchive
Theses and Dissertations
2016-03-01

The Role of Hypoxia on Pyruvate Kinase M2, mammalian Target
of Rapamycin, Mitochondrial Function, and Cell Invasion in the
Trophoblast
Rebecca Lutz Kimball
Brigham Young University - Provo

Follow this and additional works at: https://scholarsarchive.byu.edu/etd
Part of the Cell and Developmental Biology Commons, and the Physiology Commons

BYU ScholarsArchive Citation
Kimball, Rebecca Lutz, "The Role of Hypoxia on Pyruvate Kinase M2, mammalian Target of Rapamycin,
Mitochondrial Function, and Cell Invasion in the Trophoblast" (2016). Theses and Dissertations. 5723.
https://scholarsarchive.byu.edu/etd/5723

This Thesis is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion
in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please
contact scholarsarchive@byu.edu, ellen_amatangelo@byu.edu.

The Role of Hypoxia on Pyruvate Kinase M2, mammalian Target of Rapamycin,
Mitochondrial Function, and Cell Invasion in the Trophoblast

Rebecca Lutz Kimball

A thesis submitted to the faculty of
Brigham Young University
in partial fulfillment of the requirements for the degree of
Master of Science

Juan A. Arroyo, Chair
Benjamin T. Bikman
Brian D. Poole

Department of Physiology and Developmental Biology
Brigham Young University
March 2016

Copyright © 2016 Rebecca Lutz Kimball
All Rights Reserved

ABSTRACT
The Role of Hypoxia on Pyruvate Kinase M2, mammalian Target of Rapamycin,
Mitochondrial Function, and Cell Invasion in the Trophoblast.
Rebecca Lutz Kimball
Department of Physiology and Developmental Biology, BYU
Master of Science
This thesis will be organized into two chapters discussing the role of hypoxia in the
human placenta. The goal of this thesis is to characterize pyruvate kinase M2, mammalian target
of rapamycin, mitochondrial function, and cell invasion in hypoxic conditions in the trophoblast.
Understanding the mechanisms of placental metabolism can lead to further treatments for
placental diseases.
Chapter one covers the background of intrauterine growth restriction, hypoxia, placental
metabolism, and pyruvate kinase M2 (PKM2). Little is currently understood about the role of the
mitochondria in placental diseases. Expression of PKM2, trophoblast cell invasion, and
mitochondrial function is shown to be inhibited by hypoxia. PKM2 inhibition decreases
trophoblast cell invasion and nuclear expression of PKM2, but increases mitochondrial function.
Studying how hypoxia affects the placenta during placental diseases can help clarify the
mechanisms by which these diseases occur.
Chapter two further characterizes the background of intrauterine growth restriction and
hypoxia. It also covers the background of mammalian target of rapamycin. The objective of this
chapter was to assess activated mTOR in the trophoblast in hypoxia. Decreased placental and
fetal weights, as well as trophoblast cell invasion were observed in hypoxia. A decrease in the
activation of mTOR was also found in the hypoxic placenta. This study could provide insight
into the physiological relevance of the pathways and could be targeted to help alleviate placental
diseases.

Keywords: placenta, pyruvate kinase M2 (PKM2), intrauterine growth restriction (IUGR),
metabolism, mammalian target of rapamycin (mTOR)
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CHAPTER 1: The Role of Hypoxia on Pyruvate Kinase M2, Mitochondrial Function,
and Cell Invasion on Trophoblast Cells
Abstract
Introduction
Intrauterine growth restriction (IUGR) is a disease that affects many pregnant women and
their growing fetuses. Hypoxia and shallow invasion are key characteristics of IUGR. A lack of
oxygen has been shown to affect the mitochondria, which produces the energy in the cell.
Pyruvate Kinase M2 (PKM2) is a metabolic enzyme known to be involved during hypoxia. Our
objective was to determine the role of hypoxia in mitochondrial function, trophoblast cell
invasion, and PKM2.
Methods
Human placenta tissues were collected at term to characterize the mitochondria in the
cells. Human trophoblast cells were used to determine PKM2 expression. Treatment was with
hypoxia, Shikonin, or Rapamycin to observe mitochondrial function and invasion characteristics
of the trophoblast cells. The cells were lysed after treatment and western blots were performed to
view PKM2 expression.
Results
Hypoxic treated cells showed a decrease in mitochondrial function, invasion, and nuclear
and cytostolic PKM2. Shikonin treated cells showed a decrease in invasion and nuclear PKM2,
and an increase in mitochondrial function.

1

Discussion and Conclusion
We conclude that PKM2, invasion, and mitochondrial function are all decreased in
hypoxia. This could be part of the mechanism of the placental insufficiency observed during
IUGR.
Introduction
Intrauterine Growth Restriction (IUGR)
Intrauterine Growth Restriction (IUGR) is a condition during pregnancy that leads to an
increased risk of morbidity for the fetus. This disease is characterized by a fetus that does not
grow according to its genetic growth potential and is below the 10% in birth weight (Bahr et al.;
Cohen et al., 2016). This can also be called small for gestational age. IUGR can affect up to 10%
of pregnancies (Bahr et al.). IUGR complications include persistent pulmonary hypertension for
the newborn, perinatal hypoxia and asphyxia, and neurological delays (Brar and Rutherford,
1988; Gray et al., 1999; Pollack and Divon, 1992). It has also been linked to the adult onset of
diabetes, hypertension, stroke, and death from coronary vascular diseases (Arroyo et al., 2008).
Up to 44% of preterm birth (PTB) is connected with this disease (Arroyo et al., 2008). It is
associated with up to 70% of neonatal deaths and leads to increased incidence of cerebral palsy,
neurological defects, and pulmonary disorders in the neonate (Challis et al., 2001). Placental
insufficiency is the most common cause of IUGR. IUGR placentas are pathologically
characterized by decreased trophoblast invasion, reduced syncytiotrophoblast surface area, and
increased placental trophoblast apoptosis (Ishihara et al., 2002; Krebs et al., 1996; Mayhew et al.,
2003).
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Hypoxia, IUGR, and Placental Metabolism
In order to have a successful pregnancy, proper oxygenation of the placenta and fetus is
essential (Huppertz, 2014). Local hypoxia has been thought to play an important role during
IUGR. It has been shown that induced transient uteroplacental hypoxia causes significant IUGR,
confirming an important role for hypoxia during this disease (Tanaka et al., 1994). Studies have
shown that when a fetus experiences hypoxic stress, its cardiac output is redistributed to the heart
and the brain at the expense of other organs. This leads to metabolic and cardiovascular
disturbances in adulthood (Bourque et al., 2012; Giussani and Davidge, 2013; Iqbal and Ciriello,
2013; Jang et al., 2015; Matheson et al., 2015; Myatt, 2006; Rueda-Clausen et al., 2014). Other
studies have shown that hypoxia can affect the differentiation and growth of trophoblast cells.
This suggests a role for hypoxia in the function and behavior of trophoblast cells (Caniggia and
Winter, 2002; Genbacev et al., 1997; Jiang et al., 2000; Nelson et al., 1999).
Mitochondria are the powerhouses of the cell, producing the majority of energy needed
for regular cellular functions. Mitochondria need oxygen to produce ATP through the electron
transport chain and oxidative phosphorylation (Mandò et al., 2014). Dysfunctions of the
mitochondria lead to many different disorders. In the placenta, proper metabolism is important
for a successful pregnancy. During pregnancy, the metabolic activity is sustained throughout
gestation by increasing mitochondrial activity (Leduc et al., 2010). Placenta metabolism is
associated with oxygen availability and uses almost 40% of the uteroplacental oxygen uptake
(Bahr et al.). Problems in this process could contribute to many placental pathologies, including
IUGR. In previous studies, it has been shown that proper mitochondrial function is required for
normal development. Impaired mitochondrial function affects the fetal and placental growth in
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the embryo (Wakefield et al., 2011). This paper will investigate the effects of hypoxia on
mitochondrial function in placental cells.
An important enzyme involved in metabolism is Pyruvate Kinase M2 (PKM2). PKM2 is
an enzyme that catalyzes the last and rate-limiting reaction in the glycolytic pathway. This kinase
is mainly found in the developing embryo and cancer cells (Wong et al., 2013). The role of
PKM2 and mitochondrial function in cancer cells has been well established. Previous studies
have shown that PKM2 can be inhibited by oxidative stress in cancer cells (Abate et al., 1990).
The cell redirects carbon from oxidation to the anabolic pathways when PKM2 is inhibited.
PKM2 is active when oxidative stress is low (Wallace, 2012). Placental cells are reminiscent of
cancer cells in the way they invade the uterus during implantation. Recent experiments have
shown PKM2 expression in normal, preeclamptic (PE), and IUGR pregnancies with higher levels
present in preeclamptic human placentas (Bahr et al.). Further studies need to investigate the role
of PKM2 in the invasive trophoblast.
An important regulator of cell growth is the mammalian target of rapamycin (mTOR)
protein. It responds to the availability of growth factors and nutrients (Jansson et al., 2006;
Wullschleger et al., 2006). Previous studies have shown a direct correlation between mTOR
activation and trophoblast invasion (Knuth et al., 2015). Our laboratory has recently shown that
activated placental mTOR is decreased near term during hypoxia-induced IUGR in the rat
(Kimball et al., 2015). The exact metabolic role of mTOR in the placenta is still unknown.
Investigating the mTOR pathway in relation to mitochondrial function will provide valuable
insight into IUGR pathology.
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Materials and Methods
Human Placental Tissues
Paraffin-embedded placental tissue slides for Control, Preeclampsia, and IUGR placenta
were purchased from the Research Center for Women’s and Infant’s Health BioBank, Ontario,
Canada. The placentas were collected shortly after delivery either by C-section or vaginally. For
each group, ten samples were analyzed. IUGR samples were confirmed by ultrasound with a
uterine Doppler and absent end diastolic flow. IUGR samples showed placental insufficiency and
came from patients with an estimated fetal weight below the 10th percentile. Preeclampsia was
confirmed by increased maternal blood pressure and proteinuria.
Immunofluorescence
Immunofluorescence (IF) was performed on paraffin-embedded placental samples. In
summary, slides were de-waxed, washed in a 1× Tris buffer solution (TBS), and blocked with
Background Sniper (Biocare Medical, Concord, CA, USA) for 1 hr. This was followed by
incubation overnight with a primary COX IV antibody (Cell Signaling Technology, Danvers,
MA, USA), or Cytokeratin 7 (Dako, Carpinteria, CA, USA). Slides were then incubated for 1 hr
with donkey anti-rabbit TR or donkey anti-mouse TR (Biocare Medical). 4′, 6-diamidino-2phenylindole, dihydrochloride (DAPI) was used for counterstaining prior to mounting with glass
coverslips. Slides were viewed using a Texas Red excitation and emission filter.
Immunohistochemistry
Immunohistochemistry (IHC) was performed on trophoblast cells as previously shown in
our lab (Arroyo et al., 2010a). In summary, slides were de-waxed, washed in a 1x Tris buffer
solution (TBS), and blocked with Sniper for 1 hr. This was followed by incubation for 1 hr with
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a primary antibody (PKM2-Cell Signaling Technology, Danvers, MA, rabbit #4053, IgG
negative control-Biocare Medical, Concord, CA). Slides were then incubated with Mach 2
universal stain polymer, followed by color development with diaminobenzidine (DAB).
Hematoxylin was used for nuclear counterstain. Slides were mounted using Permount media.
Cell Culture Protocol
A first trimester human trophoblast Swan 71 cell line was used in this study. This cell
line was a generous gift from Dr. Gil Mor at Yale University. Cells were maintained in a 37°C
incubator in RPMI media supplemented with 10% fetal bovine serum (FBS) and penicillin and
streptomycin (P/S). For hypoxia treatments, cells were maintained in a 37°C incubator in 2%
oxygen for 24 hr before used in invasions, mitochondrial function tests, or lysed. For treatments
with Shikonin, Shikonin was purchased from Sigma-Aldrich and dissolved in dimethyl sulfoxide
(DMSO, Sigma, St. Louis, MO). The cells were treated with a final concentration of 1.0 µmol
Shikonin for 24 hr before used in invasions, mitochondrial function tests, or lysed.
Cytoplasmic and Nuclear Extraction
After treatment, trophoblast cells were separated into cytoplasmic and nuclear extracts
following the protocol accompanying the NE-PER Nuclear and Cytoplasmic Extraction Reagents
kit (Thermo Scientific, Rockford, IL #78835). Cells were combined in a microcentrifuge tube
with ice cold CER I. Microcentrifuge tubes were vortexed at the highest setting for 15 s, and
incubated on ice for 10 min. Next, ice cold CER II was added to the tube and vortexed at its
highest setting for 5 s, incubated on ice for 5 min, and vortexed again for 5 s. Tubes were
centrifuged at 16,000 x g and 4°C for 5 min. Supernatants were collected into clean, chilled, prelabeled microcentrifuge tubes and kept on ice. These were the cytoplasmic extracts. Remaining
pellets in the old microcentrifuge tubes were re-suspended with ice cold NER, placed on a vortex
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at the highest setting for 15 s, and incubated in ice for 10 min. This was repeated 3 times for a
total incubation time of 40 min. Microcentrifuge tubes were again centrifuged at 16,000 x g and
4°C for 10 min. Supernatants were collected into clean, chilled, pre-labeled microcentrifuge
tubes and kept on ice. These were the nuclear extracts.
Invasion Assay Protocol
To determine real-time invasion of trophoblast cells, an xCELLigence RTCA DP (RealTime Cell Analysis Dual Plate) instrument from ACEA Biosciences Inc., San Diego, CA, USA
was utilized. For this, cell invasion was performed using the 16-well CIM-plate. These plates are
composed of an upper and lower chamber, each containing 16 wells. The top wells were coated
in a 1:40 matrigel concentration and incubated for 4 hr. Treated and untreated trophoblast cells
were plated in the top chamber at a concentration of 20,000 cells/well in 2% FBS RPMI in a total
volume of 100 lL. The bottom chamber wells were filled with 160 lL of 10% FBS RPMI. The
cells will then be placed in the RTCA DP instrument, and invasion readings will be taken every
15 min for the next 24–50 hr.
Mitochondrial Respiration Protocol
Mitochondrial function was tested as previously shown (Tippetts et al., 2014). Highresolution O2 consumption was determined at 37°C in permeabilized cells (Sw71) using the
Oroboros O2K Oxygraph with MiR05 respiration buffer. First, a baseline respiration was
determined. Then, the sample was added into the respiration chambers. The chambers were then
hyperoxygenated to ~350 nmol/ml. The substrate-uncoupler-inhibitor-titration (SUIT) protocol
(Smith et al., 2013) was followed to determine respiration by parts or all of the following:
electron flow through complex I was supported by glutamate + malate (10 and 2 mM,
respectively) to determine basal oxygen consumption (GMB). After stabilization, ADP (2.5 mM)
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was added to determine oxidative phosphorylation capacity (GMP). Succinate was then added
(GMSP) for complex I + II electron flow into the Q-junction. The chemical uncoupler carbonyl
cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) was added (0.05 μM, followed by 0.025
μM steps until maximal O2 flux was reached). This determined full electron transport system (F)
capacity over oxidative phosphorylation. The Complex II-supported ETS was then measured by
inhibiting complex I with rotenone (Rot; 0.5 μM). Adding cytochrome c (10 μM; GMcP) allowed
us to test mitochondrial membrane integrity. Lastly, residual oxygen consumption was measured
by adding antimycin A (2.5 μM) to block complex III action. This stopped any electron flow and
provided a baseline rate of respiration.
Western Blot Analysis
Western blot analysis was used to determine expression of PKM2, phospho PKM2, and
Beta-Catenin in trophoblast cells as previously shown (Arroyo et al., 2009). Cell lysates (50 μg)
were separated on 4–12% Bis‐Tris gel SDS‐PAGE and transferred to nitrocellulose membranes.
Membranes were incubated with antibodies against phospho PKM2, total PKM2, and BetaCatenin (all from Cell Signaling Technology, Danvers, MA). Membranes were then incubated
with a secondary horseradish peroxidase (HRP)‐conjugated antibody for 1 h at room
temperature. The membranes were incubated with ECL substrate, and the emission of light was
detected using x‐ray film. To determine loading consistencies in cytostolic lysates, each
membrane was stripped and reprobed with an antibody against mouse β actin (Sigma Aldrich, St.
Louis, MO). To determine loading consistencies in nuclear lysates, each membrane was stripped
and reprobed with an antibody against rabbit Lamin B (Sigma Aldrich, St. Louis, MO).
Expression levels of the proteins were then quantified by densitometry normalized to β actin
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expression or Lamin B and changes in expression compared to the untreated controls were
reported.
Statistical Analysis
Results were checked for normality and data are shown as means ± SE. Wilcoxon rank‐
sums test was used to compare RNA and protein differences between groups, and P < 0.05 is
considered significant.
Results
Mitochondrial Function in Normal and Complicated Pregnancies
First, we wanted to identify mitochondrial content in normal and complicated
pregnancies. We investigated the placental pathologies, PE and IUGR. We performed
immunofluorescence on human placental tissues from PE, IUGR, and normal pregnancies
staining with Cox IV. We report decreased Cox IV expression in both PE and IUGR tissues
compared to the control tissue (Figure 1.1). This supports our hypothesis that mitochondrial
function is affected during placental diseases.
Mitochondrial Function in Invasive Trophoblast During Hypoxia
Since mitochondrial function was affected in the placenta during complicated
pregnancies, we next wanted to investigate mitochondrial function in vitro in human trophoblast
cells. Trophoblast cells were treated in an incubator with 24 hr of hypoxia to induce IUGR
conditions. We observed a decrease (p<0.02) in mitochondrial respiration in cells treated with
hypoxia compared to the control cells in normoxic conditions (Figure 1.2). To further
characterize the effects of hypoxia and decreased mitochondrial function on trophoblast cells, we
next studied the affect hypoxia has on trophoblast invasion. We found that trophoblast cell
9

invasion was significantly decreased (p<0.05) in those that were treated with hypoxia (Figure
1.3A). In previous studies in our lab, we have shown that mTOR is reduced in hypoxia. The
mTOR family of proteins are involved in the metabolism of many cells. To explore the
relationship between mTOR and mitochondrial function in trophoblast cells, we first
significantly inhibited (p<0.05) mTOR expression with Rapamycin (Figure 1.3B). This
inhibition results in a significant decrease of trophoblast invasion (p<0.05) in trophoblast cells
treated with Rapamycin compared to control cells (Figure 1.3C). To further identify the role of
metabolism, hypoxia, and invasion of trophoblast cells we next investigated the expression of
PKM2 during mTOR inhibition. When mTOR activation was reduced, we observed a significant
decrease (p<0.05) in PKM2 expression (Figure 1.3D). After observing the connection between
mTOR, hypoxia, and PKM2, we wanted to characterize PKM2 expression in trophoblast cells.
We performed IHC on trophoblast cells to determine cellular localization of PKM2 in these cells.
We observed an overall expression of PKM2 localized to the nucleus of the invasive trophoblast
cells (Figure 1.4A). We next investigated the effect hypoxia has directly on PKM2 in trophoblast
cells. We found a significant decrease in cytostolic total PKM2 (p<0.003) and phospho PKM2
(p<0.0006) when cells were treated in hypoxic conditions (Figure 1.4B and 1.4C). Our results
also indicated a significant decrease in nuclear total PKM2 (p<0.003) and phospho PKM2
(p<0.0002) in cells treated with hypoxia (Figure 1.4D and 1.4E). These data supported a role for
hypoxia in mitochondrial function, invasion, and the expression of PKM2 in trophoblast cells.
The Specific Role of PKM2 in Mitochondrial Function and Trophoblast Invasion
To investigate the effects of inhibiting PKM2 in trophoblast cells, we used Shikonin, a
compound known to inhibit PKM2. We first looked at the effect PKM2 inhibition has on
trophoblast invasion. After treating trophoblast cells with Shikonin for 24 hr, we observed a
10

significant decrease (p<0.02) in cell invasion. (Figure 1.5A). We next explored mitochondrial
respiration in trophoblast cells where PKM2 was inhibited. Interestingly, we found an increase
(p<0.02) in mitochondrial respiration in cells treated with Shikonin compared to the control cells,
except in baseline respiration (Figure 1.5B). In order to understand more the mechanism by
which Shikonin works, we lysed cells treated with Shikonin and looked at PKM2 expression. We
observed a significant decrease in nuclear PKM2 (p<0.03) and phospho PKM2 (p<0.04)
compared to control cells (Figure 1.6C and 1.6D). We found no significant changes, however, in
cytostolic PKM2 and phospho PKM2 in cells treated with Shikonin compared to control cells
(Figure 1.6A and 1.6B).
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Figure 1.1: Cox IV Expression in Control, IUGR, and Preeclampsia Human Placental Samples.
Cox IV staining is significantly decreased in IUGR and Preeclampsia.
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Figure 1.2: Mitochondrial Function in Trophoblast Cells in Hypoxia and Normoxia. Trophoblast
cells were treated for 24 hr in the presence or absence of hypoxia. Following treatment, the rate
of oxygen consumption was determined using SUIT1 (see the materials and methods section for
details). Cells treated with hypoxia had decreased mitochondrial function.
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Figure 1.3: Trophoblast Cell Invasion, mTOR, and PKM2. Trophoblast cells show a decreased
invasion after treatment with hypoxia (A). mTOR activation was reduced with treatment with
Rapamycin (B). This reduction in mTOR correlated with impaired cell invasion in trophoblast
cells (C) and a decrease in PKM2 (D).
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Figure 1.4: Characterization of PKM2 Expression in Trophoblast Cells. IHC showed mostly
nuclear expression of PKM2 in the invasive trophoblast cells (A). Western blots showed a
decrease in nuclear and cytostolic PKM2 and p-PKM2 expression in the invasive trophoblast
cells treated with 24 hr of hypoxia (B-E).
15

Figure 1.5: Mitochondrial Function and Cell Invasion After Treatment with Shikonin.
Trophoblast cells were treated with 24 hr of Shikonin to inhibit PKM2. Following treatment, the
rate of oxygen consumption was determined using SUIT1 (see the materials and methods section
for details). Cells treated with Shikonin had increased mitochondrial function (A). Trophoblast
cell invasion was inhibited with treatment with Shikonin (B).
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Figure 1.6: Characterization of PKM2 After Treatment with Shikonin. Trophoblast cells were
treated with 24 of Shikonin. Treatment had no significant effect on cytostolic PKM2 and pPKM2 (A and B). Nuclear PKM2 and p-PKM2 were decreased with treatment (C and D).
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Discussion
A key characteristic of IUGR is a lack of oxygen getting to the fetus from the placenta
(Arroyo et al., 2009). In order to study this disease, we used a hypoxia model similar to previous
studies to induce IUGR in trophoblast cells (Kimball et al., 2015). In the cell, oxygen is vital to
proper to mitochondria function. It allows the mitochondria to go through oxidative
phosphorylation and produce the maximum amount of ATP (Mandò et al., 2014). Knowing this
information, our lab wanted to investigate the role of hypoxia in mitochondrial function in the
placenta. We first wanted to characterize the mitochondria in human placental tissue in
complicated pregnancies. By staining with Cox IV we were able to show a decrease in
mitochondrial functioning in PE and IUGR as compared to term control placentas. This
confirmed our hypothesis that mitochondria are affected in placental diseases related to a lack of
oxygen. This data is also supported by other studies that have shown a decrease in mitochondrial
DNA in IUGR placentas (Diaz et al., 2014). To further characterize the affect hypoxia has on
mitochondrial functioning and invasion of trophoblast cells, mitochondrial respiration was
determined during normoxia or hypoxia treated cells. Our results showed a decrease in
respiration in the hypoxia treated cells in every stage of the protocol. This indicates that a lack of
oxygen not only decreases mitochondrial content, but also decreases its respiration.
Trophoblast cell invasion in the uterus requires a great deal of energy (Knuth et al.,
2015). Because the mitochondria provide the energy for the cell, we wanted to look at the
relationship between mitochondrial function and trophoblast invasion. We performed an invasion
assay comparing the invasiveness of trophoblast cells treated with hypoxia to those that were
treated with normoxia. Our results showed a significant decrease in invasion in hypoxic cells.
This established a relationship between a decrease in mitochondrial function and a decrease in
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trophoblast invasion. Our laboratory recently published a paper showing evidence that hypoxia
decreases the cell growth regulator, mTOR (Kimball et al., 2015). This led us to research the
interaction between mTOR and the mitochondria. After inhibiting mTOR, we found a decrease
in PKM2, a metabolic enzyme key to glycolysis. We also observed a decrease in trophoblast
invasion when mTOR was inhibited. This led us to further investigate PKM2 in trophoblast cells.
Through IHC, we were able to see that PKM2 is expressed mainly in the nucleus of trophoblast
cells. Next, we wanted to characterize PKM2 in hypoxic conditions. After treating the cells in
hypoxia and lysing them, we saw a depletion of both nuclear and cytostolic PKM2 and p-PKM2.
This leads us to believe that hypoxia not only inhibits mTOR, but PKM2 as well. These data
gave us further evidence connecting hypoxia, trophoblast invasion, and mitochondrial function.
Knowing that PKM2 is expressed in trophoblast cells and that it is reduced in hypoxia,
we wanted to explore the effects of inhibiting it in trophoblast cells. We first investigated the
effect it has on trophoblast cell invasion. We found that after treating the cells with a known
PKM2 inhibitor, Shikonin, cell invasion was decreased. This data gives evidence that PKM2 is a
key part of trophoblast cell invasion. It is important to note that recent studies have reported that
Shikonin inhibits migration and invasion in glioblastoma cells through inhibiting matrix
metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) (Zhang et al., 2015).
This data along with our laboratory’s data gives us new insight in how Shikonin inhibits
invasion. Next, we looked at the effect inhibiting PKM2 had on mitochondrial function. Our
results showed that mitochondrial function was actually increased after treating the cells with
Shikonin. The mechanism by which Shikonin inhibits PKM2 is unknown. To better characterize
this, we treated the cells with Shikonin and lysed them. We found a decrease in nuclear PKM2
and p-PKM2. Cytostolic PKM2 and p-PKM2, however, were not significantly affected. This
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gives evidence that Shikonin inhibits PKM2 through the nucleus. Interestingly, cytostolic pPKM2 was increased with Shikonin, though not significantly. This could provide more insight
on why Shikonin increases mitochondrial function. These unexpected results need to be further
studied to explain how Shikonin relates to mitochondrial function.
Our results could suggest possible targets to investigate in order to alleviate IUGR. They
could provide insight into the pathogenesis of this disease. Additional research of PKM2 and
mitochondrial function in the hypoxic trophoblast could provide evidence for a therapeutic
treatment for IUGR fetuses.
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CHAPTER 2: Hypoxia Reduces Placental mTOR Activation in a Hypoxia-Induced
Model of Intrauterine Growth Restriction
Abstract
mTOR is a protein that regulates cell growth in response to altered nutrient and growth
factor availability. Our objective was to assess activated mTOR and its intracellular
intermediates p70, and 4EBP1 in placental and invasive trophoblast cells in a hypoxia-induced
model of IUGR in rats. Rats were treated with hypoxia (9%) for four days. Placental and fetal
weights, as well as conceptus numbers were recorded at the time of necropsy.
Immunohistochemistry was used to determine the level of trophoblast invasion and apoptosis.
Western blots were used to determine the activation of mTOR, p70, and 4EBP1 in the placenta
and the uterine mesometrial compartment. We observed: 1) decreased placental (21%) and fetal
(24%) weights (p<0.05) 2) decreased trophoblast invasion 3) significantly increased active
4EBP1 (28%; p<0.05) in invasive trophoblast cells yet no changes in the activation of mTOR
and p70 proteins, and 4) a significant decrease in the activation of mTOR (48%; p<0.05) with no
differences in p70 or 4EBP1 activation in the placenta. We conclude that the development of
IUGR is correlated with decreased activation of the mTOR protein in the placenta and increased
4EBP1 activity in the invading trophoblast. These results provide important insight into the
physiological relevance of these pathways. Furthermore, modification of these and other related
targets during gestation may alleviate IUGR severity.
Introduction
Intrauterine growth restriction (IUGR) is an obstetric complication linked to an increased
risk of morbidity and mortality for the fetus. This disease is characterized by low birth weight
(below the 10th percentile) and it affects up to 10% of all pregnancies (Bahr et al.). IUGR
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complications include perinatal hypoxia and asphyxia, neurological delays, and persistent
pulmonary hypertension for the newborn (Brar and Rutherford, 1988; Gray et al., 1999; Pollack
and Divon, 1992). This complication has also been linked to the adult onset of diabetes,
hypertension, stroke, death from coronary vascular diseases, and can lead to Preterm birth
(Arroyo et al., 2008). Placental insufficiency is the most common cause of IUGR. Placentae in
growth-restricted pregnancies are pathologically characterized by reduced syncytiotrophoblast
surface area, decreased trophoblast invasion, and increased placental trophoblast apoptosis
(Ishihara et al., 2002; Krebs et al., 1996; Matheson et al., 2015). Hypoxia has been thought to
play an important role during IUGR. It has been shown that induced transient uteroplacental
hypoxia causes significant IUGR suggesting a role localized hypoxia during IUGR (Tanaka et
al., 1994). More recently, a study had shown that exposing rodents to hypoxia induced fetal
weight reduction and IUGR, and induces metabolic and cardiovascular disturbances in
adulthood, confirming an important role for hypoxia during this disease (Bourque et al., 2012;
Giussani and Davidge, 2013; Iqbal and Ciriello, 2013; Jang et al., 2015; Matheson et al., 2015;
Myatt, 2006; Rueda-Clausen et al., 2014). In-vitro studies have demonstrated that hypoxia can
affect the growth and differentiation of trophoblast cells, suggesting a role for hypoxia in
trophoblast functioning and behavior (Caniggia and Winter, 2002; Genbacev et al., 1997; Jiang
et al., 2000; Nelson et al., 1999). To better study the molecular pathobiochemistry of IUGR, we
chose to use a maternal hypoxia-induced IUGR model in the rat. This model provides an
essential tool to study trophoblast interactions in the uterine compartment, mTOR signaling, and
apoptosis during hemochorial placentation. The rat uterine mesometrial compartment is the part
of the uterus in which the blood vessel enters and models both endovascular and interstitial
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trophoblast invasion suggesting that, similar to humans, there is a specific function for
trophoblast invasion during pregnancy in the rat (Soares et al., 2012).
The mammalian target of rapamycin (mTOR) protein regulates cell growth in response to
the availability of nutrients and growth factors (Jansson et al., 2006; Wullschleger et al., 2006).
Signaling intermediates of the mTOR pathway include the 70-kDa ribosomal protein S6kinase 1
(p70S6K) protein and the eukaryotic translation initiation factor 4E-binding protein 1 (4EBP1)
proteins. Activation of these proteins regulates transcriptional control of target genes and protein
synthesis necessary in the control of diverse response pathways (Arroyo et al., 2009). Studies
have showed that the mTOR protein is increased during IUGR, whereas placental phospho (p)p70S6K protein is downregulated (Arroyo et al., 2009; Roos et al., 2007). Such differential
responses suggest alternative mechanisms for these proteins in the placenta during IUGR that has
not yet been adequately defined. Our laboratory has shown a direct correlation between mTOR
protein activation and trophoblast invasion, suggesting a central role for this pathway in the
regulation of trophoblast invasion during IUGR (Knuth et al., 2015). We hypothesized that
maternal hypoxia will induce IUGR by regulating proteins associated with the mTOR pathway.
In the present study, we characterized the family of signaling proteins regulated by mTOR in the
placenta and in the uterine mesometrial compartment during a hypoxia-induced IUGR.
Materials and Methods
Animals and Tissue Preparation
A total of fourteen weight-matched (~400g) Holtzman Sprague-Dawley rats (HSD) were
used for this study, which was approved by the Brigham Young University Animal Care and Use
Committee (IACUC). To obtain timed pregnancies, females were caged with HSD males
overnight. The presence of sperm in a vaginal smear was designated as day 0.5 of pregnancy.
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Placentae and uterine mesometrial compartments were dissected from pregnant rats at the time of
necropsy (18.5 days of gestation; dGA). Dams, placentae and fetuses were weighed (for each an
average of 5 per litter) and tissues were snap frozen in liquid Nitrogen for RNA and protein
analysis. For immunohistochemistry (IHC) analysis, whole concepti were frozen in dry icecooled heptane. All tissue samples were stored at -80°C until used.
Environmental Chamber and Hypoxia Exposure
To induce IUGR, pregnant rats were placed in a hypoxic chamber (n=7) for four days
(14.5 dGA to 17.5 dGA). The treatment consisted of animal treated with hypoxic conditions of
9% O2. Exposed animals were labeled HX (n=7; maternal weight 426g ±12) and control (n=7;
maternal weight 393g ±7) were maintained at 21% O2. Animals were euthanized (CO2
asphyxiation and cervical dislocation) at day 18 dGA when necropsies were performed.
Immunohistochemistry
Immunohistochemistry (IHC) was performed on frozen whole conceptus sections as
previously performed in our laboratory (Arroyo et al., 2009). In summary, slides were blocked
with Sniper (Biocare Medical, Concord, CA) and incubated for one hour with a rabbit polyclonal
primary antibody against Cytokeratin 7 (CK7; Dako, Carpinteria, CA) for trophoblast
localization, anti- cleaved (active) caspase 3 (rabbit, Cell Signaling, Danvers, MA) antibody to
assess apoptosis, anti phospho mTOR (Abcam, Cambridge, MA), anti phospho 4EBP1 (Abcam,
Cambridge, MA) or with a universal IgG negative control (Biocare Medical; Concord, CA).
Slides were incubated with Mach 2 universal stain polymer (Biocare Medical, Concord, CA)
followed by color development with diaminobenzidine (DAB; brown color). Hematoxylin was
used for nuclear counterstaining.
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RNA Isolation
RNA was isolated using the Tri-reagent method (Sigma, Saint Louis, MO) as suggested
by the manufacturer. Briefly, placenta and uterine mesometrial compartment frozen tissues (100
mg) were homogenized in 1 ml of Tri-reagent, and choloroform was added. The supernatant was
transferred to a clean tube prior to the addition of cold isopropanol. Pellets were visualized and
washed in 75% DEPC/EtOH solution and allowed to air dry for 10 min. Pellets were then
resuspended in 50 µl of DEPC water and RNA was quantified using a Nanodrop.
Real Time PCR (RT-PCR)
Real time PCR was performed to determine the activation of the mTOR and mTOR
signaling associated genes. cDNA was synthesized using Oligo (dT) and SuperScript II Reverse
Transcriptase (both from Invitrogen by Life Technologies, Carlsbad, CA) by following the
protocol suggested by the manufacturer. RT-PCR was performed using SsoFast EvaGreen
Supermix (Bio-rad Laboratories, Hercules, CA), which contains a cocktail of all necessary
components excluding primers and templates. Sso7d-fusion polymerase was used as the enzyme.
Primers for rat mTOR (Fwd.-ACCAATTATACTCGCTCCCTG, Rev.GTCATAGCAACCTCAAAGCA), p70 (Fwd.-CAGAGCGGAATATTCTGGAG, Rev. CATAAATAGTTCTCCTCCACTGAG), and 4EBP1 (FWD.- GATGAGCCTCCCATGCAG,
Rev.- CCATCTCAAACTGTGACTCTTCA) were utilized with 18S primers (Fwd.GGGAGGTAGTGACGAAAAATAACAAT, REV.-CCCTCCAATGGATCCTCGTT) as a
baseline control for the various experiments. Results (ΔΔ CT) were tested for significance
against control animal tissues. Cycling conditions were as follows: 95°C for 30 seconds; 95°C
for 5 seconds; 60°C for 30 seconds; melt curve, 65°C for 2 seconds and 95°C for 5 seconds. An
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mTOR PCR array (PARN-098Z; Qiagen, Valencia, CA) was performed to identify other genes
related to mTOR signaling potentially affected by hypoxia.
Western Blot Analysis
Western blot analysis was used to determine expression of the mTOR family of proteins
in the placenta and uterine mesometrial compartment of control and treated animals as
previously shown (Arroyo et al., 2009). Cell lysates (50 μg) were separated on 4–12% Bis-Tris
gel SDS-PAGE and transferred to nitrocellulose membranes. Membranes were incubated with
antibodies against phospho-mTOR (Ser2448), total mTOR, phospho- p70 S6 kinase (SK6)
(Thr389), total p70SK6, phospho-4EBP1 (Thr37/46), and total 4EBP1 (all from Cell Signaling
Technology, Danvers, MA, excluding total p70 from Epitomics, Burlingame, CA). Membranes
were then incubated with a secondary horseradish peroxidase (HRP)-conjugated antibody for one
hour at room temperature. The membranes were incubated with ECL substrate, and the emission
of light was detected using x-ray film. To determine loading consistencies, each membrane was
stripped and reprobed with an antibody against mouse beta-actin (Sigma Aldrich, St. Louis,
MO). Expression levels of the proteins were quantified by densitometry normalized to β actin
expression and changes in expression compared to the untreated controls were reported.
Statistical Analysis
Results were checked for normality and data are shown as means ± SE. Wilcoxon ranksums test was used to compare RNA and proteins differences between groups and p < 0.05 was
considered significant.
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Results
Fetal and Placental Weights
IUGR is characterized by decreased fetal and placental weight; therefore, we first
investigated the effects of maternal hypoxia treatment on placental and fetal weights during
pregnancy. Studies were performed exposing pregnant animals from a rage of 8 to 10% O2
conditions (data not shown). Exposing animals to 9% O2 was chosen as this was the lowest
oxygen level treatment with no significant effects in viable concepti numbers as compared to
controls (Figure 2.1A). We found a 1.3-fold reduction in fetal weight (p<0.003) with a 1.2-fold
reduction in placental weight (p<0.002) in rats exposed to hypoxia at the time of necropsy
(Figure 2.1B). These data supported a role for maternal hypoxia in fetal and placental weight
deviations in this model of IUGR.
Trophoblast Invasion and Apoptosis
Shallow invasion of the trophoblast and increased placental apoptosis are hallmarks of
IUGR. We accordingly investigated trophoblast invasion and apoptosis in the placenta during
maternal -induced IUGR. Cytokeratin 7 (CK7) was used to identify the localization of
trophoblast cells in the placental villi. CK7 IHC showed decreased invasion of trophoblast cells
into the uterine mesometrial compartment in hypoxia-exposed animals compared to controls
(Figure 2.2A top panels). We next investigated whether apoptosis of the invading trophoblast
cells was affected by hypoxia exposure. To achieve this, we immunostained for cleaved (active)
caspase 3, a protein implicated in apoptosis. Hypoxia treatment showed an increased active
caspase 3 staining in the invading trophoblast cells compared to controls (Figure 2.2A bottom
panels). Immunoblotting for active Caspase 3 was performed in the placenta to semi
quantitatively determine Caspase 3-mediated apoptosis. We observed a 1.5-fold (p<0.05)
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increase in placental active Caspase 3 in treated animals when compared to controls (Figure
2.2B). Our results suggested that hypoxia is likely involved in decreased trophoblast invasion
and increased apoptosis observed in IUGR.
mTOR Family of Proteins in the Placenta and Uterine Mesometrial Compartment
To precisely clarify mTOR gene expression patterns during hypoxia-induced IUGR, we
performed real time PCR using RNA isolated from the uterine mesometrial compartment. We
observed a significant increase (2.2-fold; p<0.05) in the expression of active mTOR, p70, and
4EBP1 (Figure 2.3A) in the hypoxia group when compared to controls. An evaluation of mTOR
related genes led to the finding that vascular endothelial growth factor A (VEGF-A) was
decreased (1.7-fold; p<0.05) while significant increases were observed for the mRNA of the
protein phosphatase, regulatory subunit B (Ppp2r2b; 4.0-fold, p<0.05) and the protein kinase,
AMP-activated, gamma 3 non-catalytic subunit (Prkag3; 1.8-fold, p<0.05) in the uterine
mesometrial compartment of hypoxia-exposed rats (Figure 2.3A). We next investigated placental
mTOR family gene expression. We observed increased mTOR mRNA (1.8%; p<0.05) in
exposed animals compared to controls (Figure 2.3B). There were no significant changes in the
expression of active p70 or 4EBP1 in exposed animals compared to controls (Figure 2.3B). PCR
array of the mTOR related genes revealed increased insulin receptor substrate 1 (Irs1; 3.7-fold,
p<0.05), phosphoinositide-3-kinase, regulatory subunit 1 (alpha) (Pik3r1; 1.3-fold, p<0.05),
protein phosphatase regulatory subunit B (Ppp2r2b; 2.0-fold, p<0.05), protein kinase, AMPactivated, gamma 3 non-catalytic subunit (Prkag3; 2.6-fold, p<0.05), ribosomal protein S6 kinase
polypeptide 2 (Rps6ka2; 1.5-fold, p<0.05) and the vascular endothelial growth factor C (VEGFC; 1.8-fold, p<0.05) genes (Figure 2.3B). Only the protein kinase, AMP-activated, gamma 2
non-catalytic subunit (Prkag2) gene was decreased (1.8-fold, p<0.05) in the placenta during
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maternal hypoxia treatment (Figure 2.3B). To determine the protein changes of the mTOR
related proteins western blot was performed. Figure 2.4 shows a characteristic western blot for
the phospho and total mTOR, p70 and 4EBP1 in the uterine mesometrial compartment (Figure
2.4A) and the placenta (Figure 2.4B) of treated animals as compared to control. We first
investigated the protein levels of mTOR, p70, and 4EBP1 in the uterine mesometrial
compartment. Immunoblotting demonstrated a significant increase in 4EBP1 activation (1.8-fold;
p<0.05) in treated animals compared to controls (Figure 2.5C). IHC was performed to confirm
that 4EBP1 was spatially expressed in the invading trophoblast of the uterine mesometrial
compartment. Phospho 4EBP1 IHC was increased (Figure 2.5D, top panels) in the uterine
mesometrial compartment of treated animals when compared to controls. This activation was
present in invasive trophoblast cells (Figure 2.5D, bottom panels). There were no significant
differences in the expression of active mTOR or p70 between treated and control animals
(Figures 2.5A, and 2.5B). No changes in the expression of these markers suggested plausible
posttranscriptional regulation of mTOR and p70 in the uterine mesometrial compartment in
hypoxia-induced models of IUGR.
In the placenta, expression of active mTOR ptotein was significantly decreased (1.9-fold;
p<0.05) in exposed animals compared to controls (Figure 2.6A). However, there was no
difference in the expression of p70 and 4EBP1 proteins (Figure 2.6B and 2.6C) between the
groups. Phospho mTOR IHC was performed in the placenta to determine if decreased active
mTOR localized to trophoblast cells. Phospho mTOR staining showed that decreased mTOR
protein expression was significantly localized to the Junctional Zone (JZ) of the placenta where
robust endocrine cells are located. The JZ is also where invasive trophoblast cells are suggested
to originate (Figure 2.6D) (Ain et al., 2005). Ck7 IHC was performed to confirm the identity of
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the trophoblast cells present in the JZ. These compelling data suggested a function for placental
mTOR activation in the development of IUGR during hypoxia.
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Figure 2.1: Placental and Fetal Weight Differences During Maternal Hypoxia Treatment in the
Rat. A significant decrease in placental (1.2-fold; p< 0.002) and fetal weights (1.3-fold; p<
0.003) was observed in hypoxia (9% 02) treated animals as compared to controls (21%O2) (A).
There were no significant differences in viable and non-viable fetuses between treated and
control animals (B).
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Figure 2.2: Trophoblast Invasion and Apoptosis During Hypoxia Treatment in the Rat. CK7 IHC
showed decreased trophoblast invasion into the uterine mesometrial compartment (UMC) of
treated animals as compared controls. Active caspase 3 IHC demonstrated increased apoptosis in
invasive trophoblasts in the UMC of the treated animals when compared to controls (A). Active
caspase 3 was increased with maternal hypoxia in the placenta of treated animals as compared to
controls (B). * identifies p ≤ 0.05.
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Figure 2.3: Uterine Mesometrial Compartment and Placental mTOR Gene Activation During
Hypoxia in the Rat. mTOR, p70, 4EBP1, Ppp2r2b and Prkag3 genes were significantly induced
in the uterine mesometrial compartment of the hypoxia treated animals when compared to
controls (A). In the placenta, hypoxia induced a significant increase of mTOR, Irs1, Pik3r1,
Ppp2r2b, Prkag3, Rps6ka2 and VEGF-C and a significant decrease of Prkag2 in the treated
animals when compared to controls (B).
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Figure 2.4: Characteristic Western Blot. mTOR, p70 and 4EBP1 proteins in the Uterine
mesometrial compartment (A) and Placental (B) of control and treated animals.
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Figure 2.5: Activation of mTOR, p70 and 4EBP1 Proteins in the Uterine Mesometrial
Compartment During Hypoxia Treatment in the Rat. There were no differences in mTOR (A) or
p70 (B) activation in the uterine mesometrial compartment during maternal hypoxia treatment. In
contrast, there was a significant increase in 4EBP1 activation (1.8-fold; p<0.05) in the uterine
mesometrial compartment of treated rats when compared to controls. (C) 4EBP1 activation was
localized to the invasive trophoblast of the uterine mesometrial compartment (UCM) of the
hypoxia treated animals.
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Figure 2.6: Activation of mTOR, p70 and 4EBP1 Proteins in Placenta During Hypoxia
Treatment in the Rat. There was a significant hypoxia-induced decrease in mTOR protein
activation (1.9-fold; p<0.05) (A). In contrast, there were no significant differences in p70 (B) or
4EBP1 (C) in the placenta of treated rats when compared to controls. Decreased mTOR
activation was localized to the trophoblast in the Junctional Zone (JZ) of the placenta of the
hypoxia treated animals when compared to controls.
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Discussion
Hypoxia is known to be associated with the development of IUGR (Tapanainen et al.,
1994). We have chosen a hypoxia-induced IUGR model in the rat in order to study molecular
signaling pathways potentially involved in the progression of IUGR. In vivo maternal hypoxia
treatment induced significantly decreased fetal and placental weight, decreased trophoblast
invasion, and elevated apoptosis, all characteristics of IUGR. This treatment did not affect the
conceptus number in the treated animals compared to the control animals. These observations
support the fact that hypoxia treatment is a factor sufficient to induce IUGR characteristics in
pregnant rats during hemochorial placentation. It is important to mention that previous
publications have shown a possible sex induced differences for hypoxia treated offspring
(Giussani and Davidge, 2013; Matheson et al., 2015; Reyes et al., 2015; Shah et al., 2015). A
limitation of our study is the fact that fetal sex was not differentiated at the time of necropsy but
the decreased in fetal weights were obtained from fetuses obtained from the two uterine horns of
each pregnancy.
Because IUGR pregnancies are characterized by decreased nutrients delivered to the
fetus, we next investigated the mTOR family of proteins. The mTOR pathway of proteins is
known to regulate cell growth in response to nutrients and growth factors (Blume-Jensen and
Hunter, 2001; Jansson et al., 2006; Wullschleger et al., 2006). Previous research has identified
plausible roles for mTOR in IUGR; however, no definitive studies have been performed that
evaluate its family members in the low oxygen tension placenta. In the present study, we
investigated the mTOR pathway in both the placenta and uterine mesometrial compartment in
normal and hypoxia-induced IUGR pregnancies. The uterine mesometrial compartment showed
an increase in mTOR, p70, and 4EBP1 mRNA expression suggesting IUGR from hypoxia

37

treated animals is mediated, at least in part, by the activation of the mTOR family of genes in the
uterine mesometrial compartment. Interestingly, we also observed increased expression of the
Ppp2r2b and Prkag3 genes. These are both involved in the negative regulation of mTOR (Qian et
al., 2015). Ppp2r2b activation is known to be involved in the negative control of cell growth and
division. It is also involved in the downregulation of mTOR activation (Qian et al., 2015).
Prkag3 is a regulatory subunit of the AMP-activated protein kinase (AMPK) and it plays a role in
the regulation of energy metabolism in cells (Milan et al., 2000). AMPK regulates ATP synthesis
and is known to inhibit mTOR activation (Rehman et al., 2014). In contrast, we observed
decreased expression of VEGF-A with hypoxia treatment. VEGF-A is involved in
vasculogenesis and angiogenesis and can act as a potent vasodilator in stable vasculature
(Eriksson et al., 2002). Our results convey the concept that although maternal hypoxia activates
the mTOR family of proteins, it also activates negative regulators of the mTOR signaling
pathway and inactivates VEGF-A, a common positive regulator of mTOR (Trinh et al., 2009).
Interestingly, we only observed a significant increase in active 4EBP1 protein in the invading
trophoblast and not increased mTOR or p70. Such a discrepancy in mRNA and protein suggests
possible posttranscriptional regulation for mTOR and p70, as previously postulated by others
(Lechuga et al., 2004; Mura et al., 2014). Such regulation may perhaps include the activation of
the Ppp2r2b and Prkag3 genes. Although the mTOR mRNA was upregulated, decreased active
protein expression could lead to the overall condition of a poorly developed and immature fetus.
It is possible that mesometrial tissues attempt to compensate for hypoxia by activating 4EBP1
protein, but such a response fails to activate this anabolic pathway.
In the placenta, however, we observed a much different response. Only mTOR mRNA
was increased in the placenta. We also observed an upregulation in the mTOR positive regulators
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Irs1, Pik3r1, Rps6ka2 and VEGF-C while there was a downregulation in the mTOR negative
regulator Prkg2. Consistent with the observation in the uterine mesometrial compartment; we
observed an upregulation of the Prkag3 gene. Both Irs1 and Pik3r1 are involved in insulin
cellular processes (Pollack and Divon, 1992; Wullschleger et al., 2006). Irs1 participates in the
transduction of signaling initiated at the activation of insulin receptors and is required for cellular
metabolism (Copps and White, 2012). Pik3r1 is involved in the insulin-mediated increase of
glucose uptake (Miled et al., 2007). IUGR is characterized with decreased amino acids and
growth factors, which can affect placental metabolism. Therefore, the activation of Irs1 and
Pik3r1 is in accordance with a variety of mechanisms related to fetal metabolic adaptations. For
example, increasing peripheral insulin sensitivity for glucose utilization and decreasing insulin
sensitivity for protein synthesis during IUGR are plausible maternal responses in an attempt to
ensure fetal survival during these low nutrients conditions (Thorn et al., 2011). Rps6ka2 and
VEGF-C genes are involved in promoting cell growth motility and survival, suggesting that,
similar to Irs1 and Pik3r1, induction could be due to a survival mechanism triggered by hypoxic
stress (Milan et al., 2000; Roux et al., 2003). In agreement with this concept are data related to
decreased placental expression of Prkag2, an mTOR negative regulator that is involved with
AMP signaling (Stapleton et al., 1996).
When we studied placental activation of mTOR, p70 and 4EBP1, only mTOR protein
activation was decreased in treated animals, while there were no differences in the expression of
p70 and 4EBP1. IHC demonstrated that decreased active mTOR was more localized to the
trophoblasts in the Junctional Zone (JZ) of the placenta, a structure suspected to primarily give
rise to invasive trophoblast cells. The importance of the JZ is underscored by the previous
observation that decreased trophoblast invasion is observed when mTOR activation is inhibited
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(Knuth et al., 2015). We therefore conclude that IUGR is correlated with increased 4EBP1
activity in the invading trophoblast cells of the uterine mesometrial compartment, decreased
activation of the mTOR protein, and decreased trophoblast invasion in the placenta during
maternal hypoxia-induced IUGR.
Our results could provide needed insight into the physiological relevance of these
pathways in the pathogenesis of IUGR and suggest possible targets that may assist in the
alleviation of IUGR. As extensions of our findings in the low oxygen tension placenta,
additional research on the mTOR pathway and the alteration of associated proteins may further
elucidate mechanistic progression factors for IUGR and provide a more effective modality for
the therapeutic treatment of growth restricted fetuses.
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